DK1493435T3 - Sammensætning af betahistin med styret frigivelse - Google Patents

Sammensætning af betahistin med styret frigivelse

Info

Publication number
DK1493435T3
DK1493435T3 DK03015172T DK03015172T DK1493435T3 DK 1493435 T3 DK1493435 T3 DK 1493435T3 DK 03015172 T DK03015172 T DK 03015172T DK 03015172 T DK03015172 T DK 03015172T DK 1493435 T3 DK1493435 T3 DK 1493435T3
Authority
DK
Denmark
Prior art keywords
controlled release
betahistine
optionally
coating layer
composition
Prior art date
Application number
DK03015172T
Other languages
English (en)
Inventor
Flavio Fossati
Anna Perachiotti
Marco Carnaghi
Luciano Marcelloni
Original Assignee
Formenti Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Formenti Farmaceutici Spa filed Critical Formenti Farmaceutici Spa
Application granted granted Critical
Publication of DK1493435T3 publication Critical patent/DK1493435T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03015172T 2003-07-04 2003-07-04 Sammensætning af betahistin med styret frigivelse DK1493435T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03015172A EP1493435B1 (en) 2003-07-04 2003-07-04 Controlled Release Compositions of Betahistine

Publications (1)

Publication Number Publication Date
DK1493435T3 true DK1493435T3 (da) 2008-09-08

Family

ID=33427119

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03015172T DK1493435T3 (da) 2003-07-04 2003-07-04 Sammensætning af betahistin med styret frigivelse

Country Status (17)

Country Link
EP (1) EP1493435B1 (da)
CN (1) CN1816323A (da)
AT (1) ATE395048T1 (da)
CY (1) CY1108551T1 (da)
DE (1) DE60320965D1 (da)
DK (1) DK1493435T3 (da)
EA (1) EA011569B1 (da)
EC (1) ECSP066267A (da)
ES (1) ES2306827T3 (da)
GE (1) GEP20084349B (da)
LT (1) LT5379B (da)
MX (1) MXPA06000090A (da)
PL (1) PL379374A1 (da)
PT (1) PT1493435E (da)
SI (1) SI1493435T1 (da)
TN (1) TNSN05326A1 (da)
WO (1) WO2005004850A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
ES2419204T3 (es) 2008-05-27 2013-08-19 The University Of Melbourne Métodos para tratar a mamíferos con disfunciones de la trompa de Eustaquio
DE102012105528A1 (de) * 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur Freisetzung von Wirkstoffen
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
PT3431078T (pt) 2017-07-20 2021-04-21 Intas Pharmaceuticals Ltd Composições orais sólidas de libertação prolongada não pulsáteis de betaistina
CN118662455A (zh) * 2019-12-21 2024-09-20 乐普恒久远药业有限公司 一种盐酸倍他司汀药物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2397840B1 (da) 1977-07-22 1981-03-20 Cherqui Jean
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
IT1229237B (it) 1989-05-08 1991-07-26 Prodotti Formenti Sali di (2-(piridil)etil) metilammina
GB9104854D0 (en) * 1991-03-07 1991-04-17 Reckitt & Colmann Prod Ltd Sustained release compositions
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
IT1309591B1 (it) * 1999-03-05 2002-01-24 Formenti Farmaceutici Spa Composizioni a rilascio controllato di betaistina.

Also Published As

Publication number Publication date
EP1493435A1 (en) 2005-01-05
EA200501908A1 (ru) 2006-08-25
LT5379B (lt) 2006-10-25
SI1493435T1 (sl) 2008-10-31
EA011569B1 (ru) 2009-04-28
EP1493435B1 (en) 2008-05-14
WO2005004850A1 (en) 2005-01-20
TNSN05326A1 (en) 2007-07-10
ES2306827T3 (es) 2008-11-16
CN1816323A (zh) 2006-08-09
PL379374A1 (pl) 2006-09-04
DE60320965D1 (de) 2008-06-26
LT2006009A (en) 2006-06-27
MXPA06000090A (es) 2006-04-07
PT1493435E (pt) 2008-08-14
GEP20084349B (en) 2008-04-10
CY1108551T1 (el) 2014-04-09
ECSP066267A (es) 2006-07-28
ATE395048T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
CY1108551T1 (el) Ελεγχομενης απελευθερωσης συνθεσεις της βεταϊστινης
EA200700132A1 (ru) Композиция таблетки пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
BRPI0411548A (pt) stent polimérico e método de fabricação
ATE386509T1 (de) Formulierung von acetaminophen und tramadol mit verzögerter freisetzung
DE60326275D1 (de) Polymilchsäurepolymerzusammensetzung zum thermoformen, polymilchsäurepolymerflächengebilde zum thermoformen und thermogeformtergegenstand daraus
NO20000284D0 (no) Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen
ATE273745T1 (de) Verfahren zur herstellung aktivstoffhaltiger kapseln mit ultradünner wandschicht
DE60211464D1 (de) Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung
AR053968A1 (es) Composiciones de polimeros antimicrobianas de liberacion controlada
BRPI0509194A (pt) formulação e método de comprimido revestido
IT1298574B1 (it) Composizioni farmaceutiche in forma di microparticelle a base polimerica ottenute mediante estrusione e sferonizzazione
NO20032737L (no) Fast termoformbar farmasöytisk sammensetning for den kontrollerte frigivelse av ivabradin
NO326689B1 (no) Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
ATE418969T1 (de) Carvedilol enthaltende pharmazeutische zusammensetzung mit kontrollierter freisetzung
CY1111666T1 (el) Απο του στοματος συνθεση ανυδρης ολανζαπινης μορφης 1
JP2004505922A5 (da)
BR0008739A (pt) Composições de liberação controlada debeta-histina
IT1320211B1 (it) Polimeri organici antiriflettenti per rivestimenti e loro procedimentodi preparazione.
DK1150704T3 (da) Melagatran til behandling af betændelse
WO2008122994A3 (en) Stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof
WO2007034287A3 (en) Oramucosal pharmaceutical dosage form
SE0302571D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0001916D0 (sv) Novel formulation
HRP20090190T1 (en) Pharmaceutical composition comprising a salt of mirtazapine
ATE369842T1 (de) Zusammensetzungen mit schneller freisetzung enthaltend cefuroxime axetil